Cisen Pharmaceutical Co Ltd (603367) — Cash Flow Quality Index
Cisen Pharmaceutical Co Ltd (603367) has a Cash Flow Quality Index of 2.04x as of September 2025. Operating cash flow of CN¥311.93 Million exceeds net income of CN¥152.86 Million, indicating high earnings quality where cash backs reported profits. Explore 603367 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cisen Pharmaceutical Co Ltd Cash Flow Quality Index (2012–2025)
Historical Cash Flow Quality Index for Cisen Pharmaceutical Co Ltd across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Cisen Pharmaceutical Co Ltd.
Annual Cash Flow Quality Index for Cisen Pharmaceutical Co Ltd (2012–2025)
Year-by-year earnings quality comparison for Cisen Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.11x | CN¥466.37 Million | CN¥421.25 Million | ▼ -0.1% |
| 2024 | 1.11x | CN¥570.85 Million | CN¥514.94 Million | ▲ +28.1% |
| 2023 | 0.87x | CN¥451.24 Million | CN¥521.34 Million | ▲ +18.1% |
| 2022 | 0.73x | CN¥258.35 Million | CN¥352.39 Million | ▲ +4.8% |
| 2021 | 0.70x | CN¥233.60 Million | CN¥333.90 Million | ▼ -29.0% |
| 2020 | 0.99x | CN¥431.01 Million | CN¥437.36 Million | ▲ +179.9% |
| 2019 | 0.35x | CN¥181.26 Million | CN¥514.79 Million | ▼ -56.4% |
| 2018 | 0.81x | CN¥406.68 Million | CN¥503.05 Million | ▼ -32.8% |
| 2017 | 1.20x | CN¥439.61 Million | CN¥365.68 Million | ▲ +0.7% |
| 2016 | 1.19x | CN¥291.97 Million | CN¥244.63 Million | ▲ +10.1% |
| 2015 | 1.08x | CN¥266.24 Million | CN¥245.62 Million | ▲ +761.8% |
| 2014 | 0.13x | CN¥27.54 Million | CN¥218.94 Million | ▼ -67.8% |
| 2013 | 0.39x | CN¥81.26 Million | CN¥208.30 Million | ▲ +234.7% |
| 2012 | 0.12x | CN¥33.09 Million | CN¥283.86 Million | — |